Pharmaceutical Supply of Labetalol Hydrochloride Injection

The contract entails the manufacture and supply of four units of Labetalol Hydrochloride Injection USP, 5 mg/mL in 40 mL vials, strictly adhering to FDA regulations, current Good Manufacturing Practices, and specialized military labeling standards. The product is identified by NSN 6505012579990 and is intended for use within the Department of Defense’s medical supply chain, ensuring compatibility with military pharmacopeial and logistical requirements. Production and delivery must meet all quality assurance benchmarks mandated for federal medical procurement, with full compliance documented to support inventory integration and battlefield readiness. Subcontracted under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, the solicitation was posted on July 20, 2026, with responses due by July 27, 2026. The place of performance is designated as Fort Stewart, Georgia, with a ZIP code of 31314-5185, indicating the primary logistics and distribution hub for the delivered product. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, and the official request can be accessed via the DIBBS portal, underscoring the transaction’s direct alignment with military pharmaceutical procurement protocols.